RadarScreener › EDIT

EDIT

Editas Medicine, Inc.
Nasdaq · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1650664) · 2 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The dilution already happened: share count is up 25%+ versus the prior period.

Radar 38 (low attention) · dilution pressure low · listing risk low · governance risk low · runway 15.4 mo · strongest signal: Share count +25% (Jun 30, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

38Radar · attention score (0–100)
36Dilution pressure · financing + balance sheet
0Listing risk · exchange standards
28Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on EDIT
Alerts
One email the morning EDIT files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for EDIT back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$181.8Mcash + short-term investments as of Jun 30, 2026
15.4 moestimated runway (FY operating cash burn)
$105.3Mstockholders' equity as of Jun 30, 2026
$191.4Mpublic float (10-K cover)
153.6Mshares outstanding as of Jul 31, 2026 · was 97.9M Apr 29, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 5, 2026· Officer/director change 8-K Item 5.02 filed 2026-08-05 (accepted 16:03 ET) filing 28
Jun 30, 2026 Share count +25% Shares outstanding 97,906,282 (2026-04-29) -> 153,580,035 (2026-07-31), +57% filing 36
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans